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Chemical synapses can be regarded as the elementary structures at which
information transfer between neurons occurs. Neurons transmit information
through the nervous system by releasing neurotransmitters from the
presynaptic terminal. In a resting state, transmitters are stored in small
organelles of uniform size and shape called synaptic vesicles. When an action
potential (stimulus) arrives in the nerve terminal, the membrane depolarizes
and voltage-gated Ca2+ channels open. The resulting Ca2+ influx triggers
fusion (exocytosis) of synaptic vesicles at specialized release sites on the
membrane, resulting in the release of neurotransmitter. This transmitter then
diffuses to and binds appropriate receptors on the postsynaptic membrane,
eliciting a response. At the same, the synaptic vesicle membrane is rapidly
retrieved by endocytosis and reutilized for the reformation of synaptic
vesicles.
Although a highly specialized process, the synaptic vesicle cycle shares
basic properties with other intracellular membrane pathways: these include
directed transport to the release site (along cytoskeletal tracks with the aid
of a motor protein) (Soldati and Schliwa, 2006), recognition of the target
membrane and docking (via rab GTPases) and fusion (executed by the
SNARE proteins (Jahn and Scheller, 2006)) followed by several specialized
steps including retrieval (interaction of synaptotagmin I with cytosolic
proteins) and refilling with neurotransmitter (by specific transporters (Ryan,
2006)). Hence, not only can synaptic vesicles be considered as the basic
minimal units of synaptic transmission but they can also be regarded as
the basic minimal units of membrane transport, whose integral protein
composition serves as the basis for all the functions that a trafficking vesicle
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must perform (including the recruitment of protein complexes from the
cytoplasm).
In fact, the composition of synaptic vesicles is, at present, better understood
than any other trafficking organelle (for a detailed characterization of their
composition see Takamori et al., 2006) and several proteins first identified
in synaptic vesicles have turned out to be members of conserved protein
families which operate in all trafficking steps (Jahn et al., 2003; Jahn and
Scheller, 2006). This is because synaptic vesicles possess several unique
properties that make them amenable to biochemical studies. Synaptic vesicles
represent the most abundant class of trafficking organelles known (e.g. the
human central nervous system (CNS) alone contains approximately 1017
vesicles), and large amounts of nervous tissue can easily be obtained in the
laboratory. They are also the most uniform class of organelle in the nervous
system, comprising a relatively homogeneous population with diameters
between approximately 40 and 50 nm, allowing the application of standard
size fractionation techniques. Finally, many of the major integral membrane
proteins are already known and provide a further basis for manipulation. In
summary, there is no other trafficking organelle of comparable simplicity and
abundance that offers biochemical access to the membrane proteins involved
in its function. This provides the opportunity of identifying novel trafficking
proteins by mass spectrometry (MS), while also providing a platform for the
optimization of existing MS protocols, using previously identified membrane
proteins.
8.1.2
Purification of Synaptic Vesicles
8.1.2.1 General Remarks
The purity of the sample is the single most important factor for a successful
proteome analysis of any isolated subcellular compartment and/or protein
complex. Therefore, much attention is currently devoted to techniques of
sample preparation. In particular, purification of synaptic vesicles requires
specialized protocols to avoid co-purification of plasma membrane fractions
and other trafficking vesicles of similar size, density or composition such
as clathrin-coated vesicles (CCVs). Therefore, it is necessary to monitor
both the enrichment and the purity of the material at various steps of the
purification procedure by the detection of highly specific marker proteins
(e.g. synaptobrevin-2, which is an integral synaptic vesicle membrane protein
critical for fusion with the plasma membrane; see below).
Synaptic vesicles can be purified in sufficient amounts from rat brain. Purifi-
cation protocols for synaptic vesicles can be divided into two major groups. The
first group involves those that separate exclusively on physical parameters, such
as shape and density (Hu et al., 2002). Synaptic vesicles prepared using these
methods involve the purification of isolated nerve terminals (synaptosomes)
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followed by osmotic lysis to release synaptic vesicles (Huttner et al., 1983).
Purification of synaptic vesicles from synaptosomes has the advantage that
small membrane fragments generated during homogenization are removed
before vesicle extraction. Although these purifications are time-consuming and
result in comparatively low yields, the vesicles obtained are of exceptionally
high purity. The second group involves immunoaffinity purification using
known vesicle proteins, for example, synaptophysin (Burger et al., 1989). Us-
ing this method, synaptic vesicles can even be isolated directly from rat brain
homogenate (without the prior isolation of synaptosomes). The crucial step in
this purification method is the homogenization phase, during which relatively
harsh conditions have to be used in order to release a sufficient amount of
synaptic vesicles from the brain.
An important general point to consider during the sample purification prior
to any proteome analysis is whether a particular purification method will
select for a biochemically distinct pool of (sub)compartments and/or protein
complexes, producing a bias in the final analysis. In neurons, the major
sources of variation will arise from (i) differential protein expression within a
population of neurons and (ii) the activity status of the cell. This variation may
be found in the integral membrane proteins, or in cytosolic factors recruited
to the synaptic vesicle at various stages of its life cycle, and is discussed in the
following paragraphs in more detail:
(i) Neurons in the brain show differential expression profiles across a
range of proteins. Nowhere is this more apparent than in the case of
the neurotransmitter transporter proteins carried on the synaptic
vesicle. To date, seven transmitter-specific transporters have been
identified, namely VMATs 1 and 2 (monoamines), VAChT
(acetylcholine), VGLUTs 1, 2, and 3 (l-glutamate), and VGAT (GABA
and glycine) (Ahnert-Hilger et al., 2003), and these show
non-overlapping but complementary expression profiles in the adult
brain. Interestingly, glutamatergic and GABAergic neurons
predominate in the CNS and this may reflect why these transporters
have been previously identified by mass spectrometry of synaptic
vesicles purified from whole brain, while those expressed at low(er)
levels (VMAT and VGAT) have remained elusive (Takamori et al.,
2006). In addition, other key vesicular proteins, which appear to be
present on every vesicle, such as synaptobrevin, synaptotagmin, and
synaptophysin, also occur in several isoforms displaying differential
localization in the CNS. At present it is impossible to say whether the
copy number of these individual vesicle proteins may vary between
different neurons, or even between individual vesicles. In addition to
the different proteomic expression pattern, some synaptic terminals
release neuropeptides from large-dense core vesicles (LDVs),
alongside the classical neurotransmitters released by synaptic vesicles
(see Chapter 10). Fusion and recycling of these LDVs utilizes many of
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the same proteins as synaptic vesicles so that differences between
these two species are hardly detectable at the proteomic level.
(ii) Synaptic vesicle composition may also be affected by the activity status
of the neuron. For instance, some synaptic vesicles seem to be
preferentially recycled and released—although it is unclear whether
this is related to the molecular composition of the vesicle or a
posttranslational modification such as phosphorylation (von
Schwarzenfeld, 1979). Recent evidence also suggests that the protein
stoichiometry of a vesicle may not be fixed and that synaptic vesicles
may exchange proteins with the plasma membrane upon fusion,
influencing its composition (Burre et al., 2006a; Wienisch and
Klingauf, 2006). Furthermore, recycling of synaptic vesicles in neurons
occurs in a clathrin-dependent manner, explaining why the vesicle
preparation contains many clathrin-related proteins, in particular the
components of the AP-2 adapter complex, responsible for coat
recruitment to the vesicle, and why partially decoated vesicles derived
from these recycling synaptic vesicles have been shown to cofractionate
with synaptic vesicles. It is still unclear whether any, or all, of these
recycling synaptic vesicles utilize an early endosomal intermediate that
would allow a further opportunity to modify the protein composition of
the vesicle. Furthermore, it should also be expected, that there will be
some variability in the recovery of soluble proteins that are recruited
from the cytosol to the vesicle at various points in the trafficking life
cycle, thus resulting in hetereogeneous vesicle populations. Indeed,
negatively stained electron micrographs of synaptic vesicles purified
from synaptosomes (although perfectly aligning in size and overall
shape) show clearly distinct surface staining suggesting different
proteins and/or quantities of proteins on the corresponding synaptic
vesicles (see Section 8.1.2.5 and Figure 8.3). This individual variation
among synaptic vesicles perhaps explains why a differential
distribution of synaptic vesicles derived from synaptosomes can be
seen in sucrose-density centrifugation (Maycox et al., 1992).
8.1.2.2 Purification of Synaptic Vesicles from Synaptosomes
The standard purification procedure for purification of synaptic vesicles from
synaptosomes is based on a modified version of a classical fractionation
protocol originally developed by Whittaker and co-workers (Nagy et al., 1976;
Huttner et al., 1983). It can be divided into six major steps: (i) homogenization
of whole rat brain, (ii) differential centrifugation of the homogenate to obtain a
crude synaptosomal pellet, (iii) hypo-osmotic lysis of the syaptosomes to release
synaptic vesicles, (iv) differential centrifugation of the crude synaptosomal
lysate to obtain a crude synaptic vesicle fraction, (v) purification of the synaptic
vesicles by continuous sucrose-density gradient centrifugation and (vi) size-
exclusion chromatography on controlled-pore glass. The purificationprocedure
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Figure 8.1 Purification of synaptic vesicles
from rat brain. Diagram for the purification
of synaptic vesicles according to (Huttner
et al., 1983). After non-equilibrium sucrose
density gradient centrifugation, the zone
between approximately 0.04 and 0.4 M
sucrose (gray) was collected and separated
by chromatography on controlled-pore glass
beads (CPG). See text and Section 8.4.1 for
further details.
8.1.2.3 Purification of Synaptic Vesicles by Immunoisolation
Analytical amounts of synaptic vesicles may also be obtained by using
immunoaffinity purification, which takes advantage of the high binding affinity
and specificity of an antibody for its antigen to allow large quantities of synaptic
vesicles to be isolated rapidly. Immunoisolation has been performed both
from crude brain homogenate and from isolated synaptosomes. Obviously,
using a crude brain homogenate largely avoids the damaging steps associated
with purification from synaptosomes (such as osmotic stress), although extra
care has to be taken to maintain sample purity. In both cases, the time-
consuming size-exclusion chromatography employed in other methods is
avoided (Huttner et al., 1983). Moreover, immunoisolation can be used to
isolate a distinct synaptic vesicle population, for instance those containing a
specific neurotransmitter transporter (see above).
144 8 Proteome Analysis of Synaptic Vesicles
Immunoisolation of synaptic vesicles has recently been carried out using
magnetic Dynabeads (Morciano et al., 2005) and the reader is referred to
this resource for more detailed protocols. The general requirements for any
bead-based system used for immunoisolation however can be summarized
as follows: the beads must be small (1–2 µm average diameter) to maximize
surface-to-volume ratio; they should be non-porous with a hydrophilic surface
and a hydrophobic core to restrict the binding of antibody to the bead surface
and to allow easy washing; and they should have almost no unspecific binding
when assayed with 35S-labeled proteins from cell-homogenates or 3H-labeled
glutamate, GABA or acetylcholine. The use of protein A/G sepharose beads
coupled with antibodies is not recommended as these beads are porous,
resulting in a large amount of ‘‘internal’’ antibody coupling which is not
accessible for binding owing to the size of the synaptic vesicles.
In general, any antibody—either affinity-purified polyclonal or mono-
clonal—can be successfully used for immunoisolation against proteins on
synaptic vesicles. Specific polyclonal antibodies have already been used for the
successful isolation of distinct synaptic vesicle populations (Takamori et al.,
2000a, 2000b). Antibodies also have the advantage that synaptic vesicles can
be eluted under less harsh condition from the beads, that is, by an excess of
the antigenic peptide. However, because finding the best antibody/coupling
conditions for immunoaffinity purification is an empirical task, and potentially
time- and resource-consuming, commercial sources of antibody are rarely an
economical option, and, at the least, researchers should consider producing
their own polyclonal antibodies.
8.1.2.4 Reducing Contaminating Peripheral Proteins
As mentioned above, the purity of a complex biological sample is an essential
prerequisite for a comprehensive analysis of its proteome. In particular, the
resolving power and dynamic range of liquid chromatography coupled to mass
spectrometry (LC-MS) are drastically decreased by highly abundant protein
components that either are naturally present or are contaminants because of
their high abundance in the cell. Either such components should be specifically
depleted (in case of a highly abundant intrinsic protein component) or the pu-
rification protocols should include an additional step to remove contaminating
proteins that interact non-specifically with the biological sample.
Synaptic vesicles obtained using either isolation technique contain various
amounts of soluble proteins with affinity for membranes such as glyceralde-
hydes phosphate dehydrogenase, aldolase, actin, and tubulin. To remove these
peripheral proteins from the synaptic vesicles, the purified vesicle fraction can
be washed with sodium carbonate (see Figure 8.2 and Section 8.2.2).
8.1.2.5 Assaying the Purity of the Synaptic Vesicle Preparation
Monitoring the purity of the sample during the various steps of purification













































































































































Figure 8.2 Fractionation of synaptic
vesicles by 16-BAC/SDS-PAGE and/or 1D
SDS-PAGE. Purified synaptic vesicles can be
resolved by either 2D (16-BAC/SDS-PAGE)
or 1D (SDS-PAGE) gel electrophoresis.
(a) In 16-BAC/SDS-PAGE gel
electrophoresis the synaptic vesicle proteins
are first fractionated by a cationic detergent
benzyldimethyl-n-hexadecylammonium
chloride (16-BAC) and secondly by
SDS-PAGE. Protein spots of interest are
labeled, excised, and digested by trypsin
prior MS analysis. (b) Alternatively, synaptic
vesicle proteins can be resolved by 1D
SDS-PAGE. To minimize the number of
(contaminating) peripheral proteins,
synaptic vesicles can be treated with sodium
carbonate prior SDS-PAGE (right panel, lane
1) or left untreated (right panel, lane 2). To
maximize the total number of identified
proteins in the MS analysis the gel can be
divided into 20–25 lanes and subsequently
digested by trypsin (left panel).
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means of assessing both the degree of enrichment and the purity of the synap-
tic vesicle preparation is immunoblotting, for which excellent antibodies are
available (e.g. Synaptic Systems, Go¨ttingen, Germany, www.sysy.com). During
purification, proteins associated with the postsynaptic density (e.g. the NMDA
receptor subunit 1 and PSD-95) should be lost, while the integral membrane
proteins of synaptic vesicles (e.g. synaptophysin) should be enriched by about
20- to 25-fold in comparison to the homogenate (Jahn et al., 1985). Contami-
nation by other subcellular compartments can also be monitored by assaying
for marker enzymes of the plasma membrane, mitochondria or endoplasmic
reticulum (Hell et al., 1988). Alternatively, although less sensitive and specific,
synaptic vesicles have a well-documented protein profile, as can be observed by
sodium dodecyl sulfate polyacrylamide-based gel electrophoresis (SDS-PAGE)
followed by staining with Coomassie Brilliant Blue (CBB). Protein bands of the
major membrane proteins of synaptobrevin (18 kDa), synaptophysin (38 kDa),
and synaptotagmin (65 kDa) are clearly visible (see Figure 8.2b).
Besides the detection of marker proteins, the morphology of synaptic vesicles
also adds very valuable information about their purity which can be checked
by electron microscopy with negative staining (Takamori et al., 2006). In the
final purification step, synaptic vesicles are identified by their small, uniform
appearance, with diameters in the range of 40–50 nm (Figure 8.3a). Final
confirmation can be obtained by immunogold labeling for the membrane
protein synaptophysin (Figure 8.3b). In a highly pure preparation more than
95% of all vesicles must be immunogold stained.
8.1.3
Proteomic Analysis of Synaptic Vesicles
To date, the identification of synaptic vesicle proteins has been limited
to biochemical and immunological techniques. The introduction of liquid
chromatography coupled to tandem mass spectrometry (LC-MS/MS) and
matrix-assisted laser desorption/ionization coupled to tandem time-of-
flight mass spectrometry (MALDI-TOF/TOF) either on-line or off-line has
provided a very powerful tool for identification of novel synaptic vesicle
proteins (Coughenour et al., 2004; Burre et al., 2006a, 2006b; Takamori et al.,
2006). Even though synaptic vesicles have been intensively studied as a
trafficking organelle, only limited information is available about the overall
protein complexity of the synaptic vesicle.
8.1.3.1 Fractionation by 16-BAC/SDS-PAGE or 1D SDS-PAGE
Some issues have to be taken into consideration when a proteomic analysis of
synaptic vesicles is to be conducted. First, it has been indicated from previous
studies that the synaptic vesicles proteome is rather complex (Takamori et al.,
2006). It is therefore recommended that the sample is fractioned prior to
MS analysis. Second, synaptic vesicles proteins are mainly membrane-bound









Figure 8.3 Electron microscopy of synaptic
vesicles. The purity and morphology of
synaptic vesicles can be checked by electron
microscopy with negative staining. Highly
purified synaptic vesicles can be obtained
from rat brain homogenate by several
differential centrifugation steps combined
size-exclusion chromatography.
(a) Negatively stained electron micrographs
of purified synaptic vesicles.
(b) Immunogold labeling of synaptic
vesicles for the known membrane protein
synaptophysin (arrows). (c) Purified
synaptic vesicles show distinct surface
staining indicating a certain degree of
heterogeneity. Panels 1 and 2 show synaptic
vesicles with a rough surface while panels 3
and 4 show more smooth synaptic vesicles
with ATPases present (arrows). Negative
staining: A solution containing synaptic
vesicles was applied to glow-discharged
carbon-coated grids and stained with 1%
uranyl acetate. Images were taken in a
Philips CM120 electron microscope (Philips
Inc.) at a defocus of 2.3 µm using a
TemCam 224A slow scan CCD camera
(TVIPS, Gauting, Germany).
Immunogold-labeling: Purified synaptic
vesicles were adsorbed to glow-discharged
formwar-coated grids and fixed with a
mixture of 4% paraformaldehyde and 0.1%
glutaraldehyde in 0.1 M potassium–sodium
phosphate buffer, pH 7.4. Thereafter
unspecific binding sides were blocked with
0.02 M glycin, and 0.5% BSA in phosphate
buffer. Labeling with 1 : 500 diluted
anti-synaptophysin antibody and 10 nm
protein A gold conjugates diluted at 1 : 1000
in 1% BSA in phosphate buffer were
performed. The samples were post-fixed for
10 min with 2% glutaraldehyde in
phosphate buffer, washed with H2O, rinsed
with three drops of 1% uranyl acetate, and
immediately dried with filter paper.
BAC/SDS-PAGE gel electrophoresis (Macfarlane, 1989; Hartinger et al., 1996).
This technique has previously been demonstrated to work very well for the frac-
tionation of membrane proteins from synaptic vesicles (Morciano et al., 2005;
Burre et al., 2006a, 2006b; Takamori et al., 2006) (Figure 8.2a andSection 8.4.3).
However, when analyzing membrane proteins, one cannot rule out the pos-
sibility that some proteins might escape detection when only one fractionation
approach is applied so that the proteome is ‘‘undersampled’’. Therefore, it
is generally advisable to apply different fractionation approaches in order to
148 8 Proteome Analysis of Synaptic Vesicles
increase the total number of proteins identified in the MS analysis (Burre
et al., 2006b; Reinders et al., 2006; Takamori et al., 2006). Accordingly, the
fractionation of synaptic vesicle proteins can also be performed by tradi-
tional one-dimensional (1D) SDS-PAGE combined with nanoLC-MS/MS or
off-line MALDI-MS/MS (Laemmli, 1970; Takamori et al., 2006). After the elec-
trophoresis, gel lanes can be cut into pieces of equal size instead of cutting
single protein bands (Figure 8.2b).
Since gel electrophoresis can be considered the first step in the separation
of complex protein samples and because proteins can be differentially stained
(or not at all) it is advisable to excise not only bands or single protein spots but
rather entire lanes on 1D SDS-PAGEs (Figure 8.2b, left panel). This strategy
ensures that proteins that are not detectable by a staining procedure still have
a chance of being identified in the subsequent MS analysis. In addition, the
total number of proteins identified is usually drastically improved when gel
lanes rather than gel spots are analyzed.
Depending on the type and size of the gel, approximately 50–200 µg of
purified synaptic vesicles can be loaded as starting material for separation
by 1D SDS-PAGE and 16-BAC/SDS-PAGE. The amount of starting material
can of course be modified as needed. Figure 8.2 shows the separation of





Purification of Synaptic Vesicles from Synaptosomes
The following method is based on the standard protocol that has been used
successfully for many years and is considered to be the ‘‘gold-standard’’
in synaptic vesicle preparation (Hell and Jahn, 1994). Slight variations in
centrifugal force and spin time have also been successfully used (Takamori
et al., 2006). Note that this method preferentially purifies synaptic vesicles
that remain membrane associated after synaptosomal lysis. At present it is
unclear whether these synaptic vesicles form a functionally distinct subset in
the synaptic terminal.
Requirements
Solutions: Homogenization buffer (320 mM sucrose, 4 mM HEPES (pH
7.40 NaOH)); 1 M HEPES (pH 7.40 NaOH); 40 mM sucrose; 50 mM sucrose;
800 mM sucrose; chromatography buffer (300 mM glycine, 5 mM HEPES
(pH 7.40, use KOH)), degassed and filtered. Protease inhibitors: 1 mg mL−1
pepstatin A in DMSO; 200 mM PMSF in 100% EtOH. Both should be stored
at room temperature until use.
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Instrumentation: Loose-fitting motor-driven glass–Teflon homogenizer,
cooled centrifuge (Sorvall RC5 or comparable with SS34 rotor), ultracentrifuge
with fixed-angle and swing-out rotors (Beckman with 50.2Ti and SW28 rotors
with corresponding tubes), equipment for column chromatography (peri-
staltic pump, UV monitor, fraction collector), Corning filter system (0.22 µm
polyethersulfone membrane), gradient mixer for forming continuous sucrose
gradients.
After collecting the brains, all steps are carried out on ice or at 4 ◦C.
1. Decapitate 20 rats (180–200 g) and remove the brains into ice-cold
homogenization buffer. Wash the brains once with homgenization
buffer to remove residual blood. Homogenize the brains in 240 mL
homgenization buffer (supplemented with 240 µL PMSF and 240 µL
pepstatin A).
2. Centrifuge the homogenate for 10 min at 850 × g. Discard the resulting
pellet P1 (containing large cell fragments and nuclei) and collect the
supernatant (S1).
3. Centrifuge the S1 for 15 min at 12 000 × g. Remove the resulting
supernatant (S2), which consists of small cell fragments such as
microsomes, small myelin fragments and soluble proteins. The
resulting pellet, P2, should be resuspended in homogenization buffer.
At this stage care should be taken to avoid the brown bottom part of the
pellet that consists of mitochodria. Centrifuge the resuspended pellet at
14 500 × g for 15 min.
4. The pellet obtained, P2′, represents a crude synaptosomal fraction. To
release synaptic vesicles from the synaptosomes, the P2′ is resuspended
(again avoiding the brown mitochondrial pellet) to yield a final volume
of 24 mL. Transfer 12 mL into a glass–Teflon homogenizer, add
108 mL ice-cold distilled water, and perform three strokes at
approximately 2000 rpm. Immediately add 600 µL 1 M HEPES-NaOH
and 120 µL PMSF. Repeat for the remaining 12 mL of tissue. Combine
both fractions and add 240 µL pepstatin A.
5. Centrifuge the suspension for 20 min at 32 500 × g to yield a lysate
pellet, consisting mainly of presynaptic plama membrane (LP1) and the
lysate supernatant LS1. The LS1 should be removed immediately and
without disturbing the LP1, which would otherwise significantly reduce
the final purity of the synaptic vesicles.
6. The LS1 is centrifuged for 2 h at 230 000 × g in a 50.2 Ti rotor. The
resulting supernatant (presynaptic cytosol; LS2) is discarded and the
pellet (LP2; crude synaptic vesicles) is resuspended in 6 mL of 40 mM
sucrose, using a small, tight-fitting glass–Teflon homogenizer running
at 900 rpm, followed by drawing it through a 20-gauge needle and
subsequently out through a 27-gauge needle.
7. During the centrifuge run prepare two linear sucrose gradients from
18 mL of 800 mM sucrose and 18 mL 50 mM sucrose. Layer 3 mL of
LP2 onto the top of each gradient and centrifuge for 4 h at 82 500 × g in
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a SW28 rotor. After centrifugation, a turbid (opaque-white) zone is
visible in the middle of the gradient (corresponding to 200–400 mM
sucrose). This fraction (25–30 mL) is collected with the aid of a
peristaltic pump and glass pipette. At this stage synaptic vesicles are
enriched approximately 10-fold over the homogenate.
8. The sample is carefully layered onto the top of a controlled-pore glass
bead (CPG-3000, see comment below) column pre-equilibrated
overnight with glycine buffer. The sample is overlaid and eluted with
glycine buffer at a flow rate of 40 mL h−1, with fractions collected every
15 min. The protein content of the eluate is monitored by absorption at
280 nm. Two peaks are obtained from the column. The first contains
small amounts of plasma membrane and/or microsomes. The second
peak contains the highly purified synaptic vesicles. Fractions
comprising the second peak are pooled and centrifuged at 225 000 × g
for 90 min. The pellet is resuspended in an appropriate buffer for
example, PBS, as in step 7. The sample can then be aliquoted and
snap-frozen, before storing at −80 ◦C. Vesicles handled show no
obvious deterioration in quality over many months.
The process of size-exclusion chromatography is omitted in many proce-
dures, although this final step has been shown to be important in separating
synaptic vesicles from residual amounts of contamination by larger membrane
fragments and soluble protein. Unfortunately the controlled-pore glass beads
usedby our lab areno longer commercially available.Analternative is Sephacryl
S-1000 (GE Healthcare) although these columns have a relatively low capacity,
do not tolerate overloading and require some experience in their use. In addi-
tion, Sephacryl columns have low flow rates, run at low pressure and have a
tendency to adsorb proteins and membrane particles, in particular during the
first few separation runs in the life of the column.Alternativemethods of synap-
tic vesicle preparation following synaptosomal lysis have also been reported,
including the use of flotation on an Optiprep step gradient (Hu et al., 2002).
8.2.2
Reducing Contaminating Peripheral Proteins
Requirements
Solutions: 0.1 M Na2CO3 (pH 11), PBS.
Equipment: Ultracentrifuge with fixed-angle and swing-out rotors (Beckman
with 50.2Ti rotor).
1. After purification, the synaptic vesicles are incubated with 0.1 M
Na2CO3 (pH 11) on ice for 15 min.
2. The synaptic vesicles are subsequently collected by ultracentrifugation
for 20 min at 50 000 rpm.
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3. Discard the supernatant after the ultracentrifugation and resuspend the
synaptic vesicles in an appropriate buffer (e.g. PBS or SDS/LDS sample
buffer).
8.2.3
Fractionation of Synaptic Vesicles by 16-BAC/SDS-PAGE Gel Electrophoresis
Requirements
Chemicals: Benzyldimethyl-n-hexadecylammonium chloride (16-BAC), urea,
glycerol, β-mercaptoethanol, glycine, phosphoric acid, Tris, acrylamide,
bisacryladmide, TEMED, SDS, FeSO4, ascorbic acid, H2O2, pyronine Y, EDTA,
glycerol, DTT.
Solutions: First dimension:
1. 2 × Sample buffer: 1 g 16-BAC, 4.5 g urea, 1 mL glycerol, 0.5 mL of
1.5 M DTT, 100 µL 5% pyronine Y (w/v) solution (in water), ddH2O to
10 mL. Solubilize detergent and urea in glycerol and 4 mL ddH2O by
heating in a microwave, then add DDT and pyronine Y. The solution is
finally brought to 10 mL with H2O.
2. Running buffer (pH 3): 2.5 mM 16-BAC, 150 mM glycine and 50 mM
phosphoric acid (a 10× solution can be prepared if needed).
3. Lower gel (7.5%): 10 mL H2O, 10 mL 300 mM potassium phosphate
buffer (pH 2.1), 10 mL AMBA (30% acrylamide, 0.8% bisacrylamide),
1.4 mL 1.7% bisacrylamide, 7.2 g urea, 400 µL 10% 16-BAC (heat to
65 ◦C to solubilize), 64 µL 0.14% FeSO4 (fresh), 2 mL 80 mM ascorbic
acid (fresh), start with 1.6 mL H2O2 (1 : 1200, diluted from 30% stock
solution, make fresh).
4. Upper gel (4%): 2.5 mL 0.5 M phosphate buffer (pH 4.1), 3.0 mL H2O,
1.33 mL AMBA, 1.38 mL 1.7% bisacrylamide, 1 g urea, 70 µL 250 mM
16-BAC (heat to 65 ◦C to solubilize), 8.5 µL 5 mM FeSO4 (fresh), 520 µL
80 mM ascorbic acid (fresh), start with 500 µL H2O2 (1 : 750, diluted
from 30% stock solution, make fresh).
5. 1 : 750 H2O2 (fresh).
6. Fixing solution: isopropanol:acetic acid:water (3.5 : 1 : 5.5).
7. Staining solution: 0.15% (w/v) Coomassie Brilliant Blue R, 25% (v/v)
propanol, 10% (v/v) acetic acid.
8. Re-equilibration solutions: (1) 100 mM Tris-Cl, pH 6.8; (2) 15% (v/v)
EtOH, 100 mM Tris-Cl, pH 6.8.
Second dimension:
1. 10 × Running buffer: 150 g Tris, 720 g glycine, 50 g SDS, add ddH2O to
5 L.
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2. Upper Tris buffer: 0.5 M Tris, 0.4% (w/v) SDS, pH 6.8.
3. Lower Tris buffer: 1.5 M Tris, 0.4% SDS (w/v), pH 8.8.
4. AMBA (acrylamide stock): 300 g acrylamide, 8 g bisacrylamide, fill up to
1 L with ddH2O.
5. 3× Sample buffer: 45 g SDS, 124.8 mL upper Tris (pH 6.8), 15.0 mL
0.1 M EDTA, 150 g sucrose or 150 mL glycerol, ddH2O to 450 mL.
Remember to add β-mercaptoethanol (10% final concentration).
6. TEMED and 10% APS.
7. Coomassie stain: 0.15% Coomassie Brilliant Blue R, 25% isopropanol,
10% acetic acid.
8. Destain: 25% isopropanol, 10% acetic acid.
16-BAC discontinuous gel (first dimension):
1. The glass plates used for the gel apparatus are first washed with ethanol
and assembled according to the manufactures instructions. The
16-BAC gel is prepared as a slab gel using a stacking gel casted on top of
a resolving gel.
2. The 7.5% resolving gel (40 mL final volume) is made accordingly to the
above method (lower gel). The polymerization is initiated by adding the
H2O2 and should be completed in approximately 30 min at room
temperature. For optimal results the gel should be allowed to
polymerize over night.
3. The 4%stacking gel prepared accordingly to the abovemethod (upper gel)
and is poured on top on the resolving gel. The polymerization is initiated
by adding H2O2 and should be completed in approx 20–30 min. Appro-
priate gel combs are inserted into the stacking gel before it polymerizes.
First-dimension electrophoresis:
1. After the comb has been removed from the gel, the wells are washed
with 1× running buffer.
2. The samples are diluted in the prepared 2× sample buffer (to 1×) and
heated for 5 min at 65 ◦C. Do not boil the samples. The samples are
then loaded on the gel.
3. Remember that the electrophoresis is carried out such that the proteins
move towards the cathode (opposite of SDS gels!).
4. For mini-gels (0.75 mm) run the gel at 10 mA/gel until the dye front
enters the separation gel, then 20 mA/gel until the dye front has
completely run out of the gel (approx 1.5 h). For larger gels
(14 × 16 cm) the current is initially 25 mA/gel and subsequent at
80 mA/gel (approx 7.5 h).
Note: Never store samples in sample buffer. Due to unfolding of the proteins
in the presence of urea they are more susceptible to proteases and can degrade
overnight. If dealing with membrane proteins which are hard to dissolve one
may tip-sonicate samples before adding sample buffer and centrifuge them
before loading.
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Staining, destaining, and re-equilibration:
1. After first-dimension electrophoresis the gel is fixed in fixing solution
for at least 1 h. Several changes should be made during fixation.
2. Stain the gel with Coomassie Blue (15–30 min).
3. Destain the gel with fixing solution (several changes).
4. For re-equilibration, the gel is first incubated for 3 × 10 min with
re-equilibration solution 1 and subsequently for 5–10 min with
re-equilibration solution 2.
5. The strip of interest is carefully excised by cutting with the edge of a
glass plate (0.3 and 0.6 cm for mini-gels and larger gels, respectively)
and stored at 4 ◦C.
Second-dimension electrophoresis:
1. The SDS-PAGE is done under standard conditions using the lower Tris
buffer for the separations gel and the upper Tris buffer for the stacking
gel. Either a gradient (9–15%) or a 10% gel can be used depending on
the complexity of the sample to be analyzed. Remember to prepare the
stacking gel with a large well that can accommodate the strip generated
from the first dimension. There should also be an extra lane for
molecular mass markers.
2. After polymerization, the gel is placed in the appropriate gel apparatus
and the well is filled with 1× running buffer.
3. Place the strip at the bottom of the well (stacking gel) with the aid of
a spatula.
4. Fill the well with 100–300 µL 3× sample buffer and incubate for 5 min.
5. The gel is first run at 5 mA for mini-gels and 12 mA for larger gels
(16 × 16 cm, 1 mm thick) until the dye front enters the separation gel.
Separation is carried out at 20 mA for mini-gels and 80 mA for larger
gels. The electrophoresis will run for approx 1 h for mini-gels and
3–3.5 h for larger gels (10%).
6. The gel apparatus is dismantled carefully and the gel stained with
colloidal Coomassie Blue stain.
8.2.4
Fractionation by 1D SDS-PAGE
This protocol is based on the use of pre-cast gels which can be bought from
several vendors. This paragraph is based on the NuPAGE system (Invitrogen).
Requirements
Equipment: Novex Bis-Tris pre-cast gels (10% or 4–12% gradient gels), gel
chamber, running buffer (MES or MOPS), molecular weight markers, LDS
sample buffer, reducing agent and power supply. The Novex Bis-Tris gels
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come in thickness of 1 mm (approx 30 µL loading capacity) and 1.5 mm
(approx 40 µL loading capacity).
Sample preparation:
1. The sample is dissolved in LDS sample buffer (1×) containing reducing
agent.
2. Heat (do not boil) the samples for 5–10 min at 70 ◦C.
3. Prepare 1 L of running buffer (MES for low molecular weight proteins
or MOPS for mid-size molecular weight proteins).
4. After heating, the sample is loaded in the gel (10% or 4–12% gradient
gel).
5. 200 mL 1× running buffer containing 500 µL reducing agent is placed
in the inner gel chamber.
6. 600 mL 1× running buffer is placed in the outer gel chamber.
Gel electrophoresis:

















After end gel electrophoresis the gel is stained with colloidal Coomassie




Equipment: Clean scalpel, spatula, 0.5 mL safe-lock reaction tubes.
8.2.5.1 Excision of Protein Spots/Lanes from 16-BAC/SDS-PAGE and 1D
SDS-PAGE gel
Protein spots/bands of interest are excised from either the 16-BAC-SDS-PAGE
or the 1D SDS-PAGE gels. A clean scalpel is used for this purpose. Cut as
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close as possible to the edge of the spot/lane to avoid extra gel material. The
excised spot/lane is further cut into smaller pieces of approx 1 × 1 mm. The
gel particles are transferred into a 0.5-mL reaction test tube.
8.2.5.2 In-Gel Reduction, Alkylation, and Digestion
Chemicals: H2O, acetonitrile, NH4HCO3, dithiothreitol, iodoacetamide,
CaCl2, formic acid, trypsin.
Solutions: 100 mM NH4HCO3 (pH 8.0), 10 mM DTT in 100 mM NH4HCO3,
55 mM iodoacetamide in 100 mM NH4HCO3, 5% (v/v) formic acid, trypsin
(0.1 µg µL−1), 100 mM CaCl2.








50 µL 50 µL
CaCl2 (100 mM) 5 µL 5 µL
H2O 50 µL 50 µL
Total 120 µL 120 µL
The amount of buffer is sufficient for approximately 10–15 digestions.
1. Wash the gel pieces with 150 µL ddH2O. Incubate for 5 min at 25 ◦C
(1.050 rpm) in a thermomixer.
2. Spin gel pieces down and remove all liquid with thin pipette tips.
3. Add 150 µL acetonitrile and incubate for 15 min at 25 ◦C (1.050 rpm)
in a thermomixer to shrink (dehydrate) the gel pieces (they become
white and stick together).
4. Spin the gel pieces down and remove all liquid.
5. Dry the gel pieces for approx 5 min in a SpeedVac.
6. Swell the gel pieces in 100 µL 10 mM DTT (the gel pieces must be
covered completely). Incubate at 56 ◦C for 50 min to reduce the
cysteine residues within the protein.
7. Spin the gel pieces down and remove all liquid.
8. Add 150 µL acetonitrile and incubate for 15 min at 25 ◦C (1050 rpm) in
a thermomixer (until the gel pieces have shrunk).
9. Spin the gel pieces down and remove all liquid with a thin tip.
10. Incubate the gel pieces with 55 mM iodoacetamide for 20 min at room
temperature in the dark to modify (alkylate) the cysteines.
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11. Spin the gel pieces down and remove all liquid with a thin tip.
12. Add 150 µL of 100 mM NH4HCO3, incubate for 15 min at 25 ◦C
(1050 rpm) in a thermomixer.
13. Spin the gel pieces down and add 150 µL of acetonitrile. Incubate for
15 min at 25 ◦C (1050 rpm) in a thermomixer.
14. Spin the gel pieces down and remove all liquid with a thin tip.
15. Shrink the gel pieces in 150 µL acetonitrile by incubating for 15 min at
25 ◦C (1050 rpm) in a thermomixer.
16. Spin the gel pieces down and remove all liquid with a thin tip.
17. Dry the gel pieces for 5–10 min in a SpeedVac.
18. Rehydrate the gel pieces at 4 ◦C in digestion buffer 1 (see above)
containing trypsin for 30–45 min. Use only small amounts of
digestion buffer. Check the samples after 15–20 min and add more
buffer if all liquid is absorbed by the gel pieces. Add 10–20 µL of
digestion buffer 2 (without trypsin) to cover the gel pieces completely
and to keep them wet during enzymatic cleavage.
19. Incubate samples in incubator at 37 ◦C overnight.
8.2.5.3 Extraction of Peptides from In-Gel Digests
1. Prepare fresh 0.5 mL reaction tubes to collect the supernatant.
2. Spin the gel pieces down.
3. Add 10–15 µL water to the digest, so that the gel pieces are completely
covered with liquid.
4. Spin the gel pieces down and incubate for 15 min at 37 ◦C and
1050 rpm in a thermomixer.
5. Spin the gel pieces down.
6. Add at least 50 µL of acetonitrile (a volume twice as large as the
volume of the gel pieces should be added) and incubate for 15 min at
37 ◦C (1050 rpm) in a thermomixer.
7. Spin the gel pieces down and collect the supernatant in the new
reaction tubes.
8. Add 50 µL of 5% formic acid to the gel pieces and incubate for 15 min
at 37 ◦C (1050 rpm) in a thermomixer.
9. Spin the gel pieces down and add 50 µL of acetonitrile, then incubate
for 15 min at 37 ◦C (1050 rpm) in a thermomixer.
10. Spin the gel pieces down and collect the supernatant and pool the
extracts in the new reaction tubes.
11. Add 100 µL acetonitrile and incubate for 15 min at 37 ◦C (1050 rpm) in
a thermomixer.
12. Spin the gel pieces down and transfer the supernatant to the pooled
extracts in the new reaction tubes.
13. Evaporate the samples to dryness in the SpeedVac (about 11/2 h).
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8.2.6
On-Line and Off-Line Nano Liquid Chromatography (NanoLC)
8.2.6.1 Pre- and Analytical Columns from Vendors
Requirements
C18-analytical columns: C18 PepMap 100, 75 µm ID, 3 µm 100 A˚ (LC
Packings). PreproSil-Pur 120 C18-AQ, 3 µm and/or 5 µm (Dr Maisch GmbH).
Onyx Monolithic C18, 100 µm ID (Phenomenex).
C18-pre columns: µ-Precolumn Cartridge; C18 PepMap 100, 300 µm ID
(5 mm length), 5 µm 100 A˚ (LC Packings).
8.2.6.2 Preparation of Pre- and Analytical Nano-Flow Reverse-Phase Columns
Requirements
Chemicals and materials: Formamide, methanol, 0.1% (v/v) trifluoroacetic
acid (TFA) in water (solvent A), 80% (v/v) acetonitrile, 0.1% (v/v)
TFA in water (solvent B), Kvasil1• (PQ Europe), fused silica capillar-Q1
ies (375 µm outer diameter (OD) and 75 µm inner diameter (ID) for
analytical columns, 375 µm OD and 150 µm ID for pre-columns (Polymi-
cro Technologies), MicroTight Fittings with 5 µM PEEK filter end fitting
(UpChurch Scientific Inc.), MicroTight Sleeve Green (0.0155 × 0.025, Up-
Church Scientific Inc.), polymer tubing PEEK Gray 1/16 × 0.015 (400 µm
ID, UpChurch Scientific Inc.), reverse-phase material (e.g. Vydac MS218,
5 µm 300 A˚ beads (Vydac) or Reprosil-Pur 120 C18-AQ, 3 µm (Dr Maisch
GmbH).
Instrumentation: Pressure vessel (for packing the columns; Bruchbuehler)
connected to a high-pressure helium cylinder. Pressure valve should allow up
to 200 bar (e.g. Messer Griesheim).
8.2.6.2.1 Generation of a ‘‘frit’’ restrictor in the fused silica capillary for
analytical columns
1. Mix 88 µL Kvasil1 and 16 µL formamide in a 1.5-mL test tube.
2. Vortex rigorously for 2–3 min (the solution becomes viscous).
3. Dip one end of a 30–40-cm-long fused silica capillary (375 µm OD
75 µm ID) in the solution for 1–2 s (the solution will move upward into
the fused silica by capillary action).
4. Wipe off excess solution. Polymerization is achieved by leaving the
capillary at room temperature overnight or by heating at 50 ◦C for 2–3 h.
5. Check the frit under the microscope/binocular. It should be 2–5 mm in
length. Cut the frit if it is too long.
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8.2.6.2.2 Packing reverse-phase analytical columns
1. The fused silica capillary (with the frit) is inserted into the pressure
vessel and the open end is placed in a reaction tube (within the pressure
vessel) containing 100% methanol. The vessel is closed properly and
the helium pressure is raised until the methanol flows through the
capillary. This step assures that the capillary is clean before
column-packing and that the frit stays intact under higher pressure.
2. Resuspend approx 5–10 mg of reverse-phase material with 500 µL
methanol in a reaction tube. Place the reaction tube in the pressure
vessel and the capillary in methanol slurry as above. Pack the column
with the slurry according to the cleaning procedure above, but with
higher pressure (up to 70 bar). In order to keep the reverse-phase
material in suspension during the packing procedure, a very small
magnetic stirrer should be put into the reaction tube and the entire
vessel should be placed on a magnetic stirring device. Column packing
can be observed under the microscope/binocular. The column should
be packed for 25–20 cm. After the helium pressure has been turned off,
the column should remain in the vessel overnight to slowly minimize
the pressure and thus avoiding any back-flushing of sample material.
3. The open end (without the frit) is covered with a peek sleeve (400 µm
ID) and is tightly fixed with a stainless nut and ferule compatible with
the valve port of the nanoLC system
4. The packed column is mounted in a capillary/nanoLC system and
equilibrated first with solvent B and then with solvent A for the 30 min
each, with a flow rate of 400–800 nL min−1 (depending on the back
pressure, which should not exceed 160 bar).
5. The performance of the column is tested in several test runs with a
tryptic digest of a standard protein (e.g. 100 fmol BSA).
Pre-columns are made in the same way as described above for analytical
columns using a fused silica with an OD of 375 µm and ID of 75 µm (for
LC-MS/MS) or 150 µm (for LC-MALDI). When pre-columns for LC-MALDI
are generated, a column (after end packing) with an approximate length of
2 cm is cut out from the fused silica and subsequently closed by MicroTight
fittings on both sides.
8.2.6.3 On-Line NanoLC-ESI MS/MS
Requirements
Chemicals: Water, acetonitrile, formic acid.
Solutions: Solvent A, 0.1% formic acid (v/v) in water; solvent B, 100%
acetonitrile (v/v), 0.1% formic acid (v/v) in water; solvent C, 0.1% formic acid
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(v/v) in water; Solvent D: 10% acetonitrile (v/v), 0.15% formic acid (v/v) in
water.
Instrumentation: Waters Q-TOF Ultima ESI mass spectrometer equipped
with a capillary LC system and autosampler. Columns from vendors and/or
self-packed pre- and analytical columns are described above.
1. Extracted peptides derived from in-gel digested synaptic vesicle proteins
are dissolved in an appropriate volume of solvent D (e.g. 20–50 µL).
2. Samples (max. 6 µL) are loaded onto the pre-column with solvent C at a
flow rate of 10 µL min−1 for 10 min.
3. Peptides are eluted onto the analytic column by backflush and
subsequently separated with the following gradient with a flow rate of
180 nL min−1: 7% (v/v) solvent B to 40% (v/v) solvent B for 50 min,
40% B to 80% B for 1 min, isocratic elution at 80% B for 10 min, 80% B
to 7% for 1 min, isocratic equilibration at 7% B for 10 min.
4. Peptides are chosen for MS/MS analysis by performing a survey scan of
the ionized species that elute from the column into the instrument
(automated MS and MS/MS analysis). The settings for the survey scan
have to be optimized according to the corresponding ESI instrument.
5. MS/MS spectra of the peptides are processed (smoothing, centroiding)
and searched against databases using Mascot as search engine
according to the above mentioned settings (see Section 8.3.4).
8.2.6.4 Off-Line NanoLC
Requirements
Chemicals: α-Cyano-cinnamic acid, water, acetonitrile, TFA (Sigma-Aldrich),
o-phosphoric acid (H3PO4, Merck).
Solutions: Solvent A, 0.1% TFA (v/v) in water; solvent B, 80% ACN (v/v),
0.1% TFA (v/v) in water; solvent C, 3.5% ACN (v/v), 0.1% TFA (v/v) in water;
MALDI matrix, 10 mg mL−1 HCCA in 70% ACN (v/v), 0.1% TFA (v/v) in
water.
Instrumentation: Dual Gradient System (Dionex) equipped with an autosam-
pler; LC-MALDI Spotter Probot (Dionex) with a 300-nL mixing chamber
(UpChurch Scientific Inc.); MALDI-TOF/TOF 4800 analyzer (Applied Biosys-
tems/Sciex MDS).
• Samples (complex peptide mixtures derived from in-gel digestion of
synaptic vesicles) are dissolved in x µL • of 10% (v/v) acetonitrile, 0.1% (v/v)Q2
TFA and injected via the autosampler onto the pre-column with solvent C at
a flow rate of 5 µL min−1 for 25 min.
• The desalted peptides are eluted from the pre-column and subsequently
separated on the analytical column by the following ‘‘standard’’ gradient:
160 8 Proteome Analysis of Synaptic Vesicles
15 min 10% (v/v) solvent B, 10–60% (v/v) solvent B for 60 min, 60–100%
(v/v) solvent B for 3 min, 100% (v/v) solvent B for 9 min, 100% (v/v) solvent
B—10% solvent B for 1 min. The gradient can be adjusted according to the
complexity of the sample.
• Fractions are spotted every 15 s onto stainless steel LC-MALDI plates
(Applied Biosystems) with α-cyanocinnamic acid as matrix. Matrix is
delivered with a flow rate of 0.9 µL min−1 and is mixed with the eluate
using a T-piece mounted in before the spotter needle.
• Fully automated MALDI-MS and MS/MS analysis of the spotted fraction is
performed according to the manufacturer’s instructions for the MALDI
instrument.
• Settings for data analysis are according to the analysis of data acquired by
LC-ESI-MS/MS, except that the number of missed cleavages (see above) for




A comprehensive proteomic analysis of highly purified synaptic vesicles
has provided a detailed map of the protein constituents involved in the
synaptic vesicle life cycle in addition to vesicle-associated proteins (Takamori
et al., 2006). These proteins include already known players in addition to
novel proteins. Since the synaptic vesicle proteome is rather complex, with
more than 400 identified proteins, the sample has to be fractionated before
MS analysis. A combination of 1D SDS-PAGE and 16-BAC/SDS-PAGE is
recommended to ensure maximum recovery of both soluble and (integral)
membrane proteins. In a new study, synaptic vesicles were fractionated by
a combination of 1D SDS-PAGE and 16-BAC/SDS-PAGE and subsequently
analyzed by nanoLC-MS/MS; this resulted in the identification of 321 and
262 proteins, respectively (Table 8.1). Of these, 149 proteins were uniquely
identified by 1D SDS-PAGE, and a further 90 proteins were uniquely identified
by 16-BAC/SDS-PAGE. Even though 172 proteins were found to be common
between the two analyses the relatively high number of unique proteins
identified in each method emphasizes that the two fractionation strategies are
complementary. As seen in Table 8.1, the proteins identified include a variety
of protein classes including trafficking proteins, small endocytosis-related
GTPases, transporters/channels, cytoskeleton proteins, cell surface protein,
signaling molecules, metabolic enzymes, chaperones, proteasome proteins,
RNA-processing proteins, and novel proteins (for a detailed description of
the individual proteins see Takamori et al., 2006). Interestingly, even though
proteomics approaches have failed to identify all known synaptic vesicle
proteins (in particular integral membrane proteins such as the low abundant
transporters and the chloride channels), the total number of identified proteins
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Table 8.1
Total Overlap 16-BAC-SDS 1D SDS
Trafficking
proteins•Q3








50 32 45 37
Other trafficking
proteins
39 22 29 32
Transporter/
channel
45 27 33 39
Cytoskeleton 29 12 14 27
Cell surface 24 7 14 17
Signaling
molecules
38 13 25 26
Metabolic
enzymes
42 15 25 32
Others 43 9 16 37
Chaperones 12 4 6 10
Proteasome 11 5 6 10
RNA processing 22 4 15 11
Novel 18 3 11 11
is still considered surprisingly high. The large number of proteins identified
can be explained to some extent by proteins that are thought to associate
only transiently with synaptic vesicles. Another explanation might be that
heterogeneous populations of synaptic vesicles exist where not all proteins
reside on the same vesicle. This phenomenon is already observed for the
transporters (i.e. VGLUT and GABA) which represent a specific pool of
synaptic vesicles (Takamori et al., 2000a, 2000b). A proteomic analysis of
different subpopulations of synaptic vesicles will therefore be helpful to
elucidate such differences. Finally it might be the case that many novel
synaptic vesicle proteins are still to be identified. These proteins include
known proteins which have not been assigned as synaptic vesicle proteins
before and proteins which have only been identified by automated genome
annotation. A functional characterization of these proteins as novel synaptic
vesicle proteins will play an important role in understanding the detailed
mechanism of the synaptic vesicle life cycle.
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Abstract: Synaptic vesicles are storage organelles for neurotransmitters in
neurons. When an action potential arrives at the nerve terminal, voltage-
gated calcium channels open and synaptic vesicles undergo rapid exocytosis,
releasing their neurotransmitter content into the synaptic cleft. The synaptic
vesicle membrane is rapidly retrieved by endocytosis and reutilized for the
reformation of further synaptic vesicles. The synaptic vesicle cycle shares
basic properties with other intracellular membrane pathways. Hence, not
only can synaptic vesicles be considered to be the basic minimal units
of synaptic transmission but also the basic minimal units of membrane
transport, and their integral protein composition serves as the basis for all
the functions a trafficking vesicle must perform. The high abundance and
homogeneity obtained from purified synaptic vesicles make them an ideal
model for improving membrane-based proteomics, in addition to identifying
novel synaptic vesicle proteins.
This chapter describes the purification and mass spectrometric analysis of
synaptic vesicles and their protein components. Successful purification of
synaptic vesicles, in respect to purity and amount, is the prerequisite for a
comprehensive proteomic analysis. The first part of this chapter addresses
this issue by focusing on the purification of synaptic vesicles from rat brain,
on the reduction of contaminants, and on how to monitor the purity of the
purified synaptic vesicles. The second part provides protocols for the isolation
of synaptic vesicles, the separation of synaptic vesicle proteins mainly by
gel electrophoresis prior to mass spectrometric analysis, and the analysis of
complex protein samples by liquid chromatography coupled either on- or
off-line.
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